Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Miles

Showing results (361-370 of 370) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 370 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 30, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UKH M Earl, L Hiller, J Dunn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2021
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognosticationD Miles, E Ciruelos, A Schneeweiss, et al.
The Journal of Biological Chemistry|March 22, 2012
Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response elementKarl E Miletti-González, Kyle Murphy, Muthu N Kumaran, et al.
Biochemistry|August 19, 2022
Structural Basis of Stereospecific Vanadium-Dependent Haloperoxidase Family Enzymes in Napyradiomycin BiosynthesisPercival Yang-Ting Chen, Sanjoy Adak, Jonathan R Chekan, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Environmental Monitoring and Assessment|May 23, 2018
The North American Forest Database: going beyond national-level forest resource assessment statisticsW Brad Smith, Rubí Angélica Cuenca Lara, Carina Edith Delgado Caballero, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Mapping multiple RNA modifications simultaneously by proximity barcode sequencingErdem Sendinc, Hua Yu, Yu Hsien Hwang Fu, et al.
Genome Medicine|June 28, 2022
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populationsTian Ge, Marguerite R Irvin, Amit Patki, et al.
Pageof 37

Showing results (361-370 of 370) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 370 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 30, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UKH M Earl, L Hiller, J Dunn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2021
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognosticationD Miles, E Ciruelos, A Schneeweiss, et al.
The Journal of Biological Chemistry|March 22, 2012
Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response elementKarl E Miletti-González, Kyle Murphy, Muthu N Kumaran, et al.
Biochemistry|August 19, 2022
Structural Basis of Stereospecific Vanadium-Dependent Haloperoxidase Family Enzymes in Napyradiomycin BiosynthesisPercival Yang-Ting Chen, Sanjoy Adak, Jonathan R Chekan, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Environmental Monitoring and Assessment|May 23, 2018
The North American Forest Database: going beyond national-level forest resource assessment statisticsW Brad Smith, Rubí Angélica Cuenca Lara, Carina Edith Delgado Caballero, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Mapping multiple RNA modifications simultaneously by proximity barcode sequencingErdem Sendinc, Hua Yu, Yu Hsien Hwang Fu, et al.
Genome Medicine|June 28, 2022
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populationsTian Ge, Marguerite R Irvin, Amit Patki, et al.
Pageof 37